Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score-Reference-Cited by-同舟云学术

Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score

Published:2008-11 Issue:9 Volume:102 Page:1133-1139
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Kaplan Steven A.,Roehrborn Claus G.,Chancellor Michael,Carlsson Martin,Bavendam Tamara,Guan Zhonghong

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2008.07761.x/fullpdf

Reference27 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003

2. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study;Glasser;Int J Clin Pract,2007

3. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

4. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies;Robertson;BJU Int,2007

5. Overactive bladder in the male patient: bladder, outlet, or both?;Abdel-Aziz;Curr Urol Rep,2002

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Advancements in Benign Prostatic Hyperplasia Treatments;Current Urology Reports;2024-03-07

2. Safety and efficacy of an α₁‐blocker plus mirabegron compared with an α₁‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis;Neurourology and Urodynamics;2024-01-30

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction;Cochrane Database of Systematic Reviews;2021-02-10

5. Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study;Urology;2021-01